MEDICAMENT CONTENANT UN INHIBITEUR DE MTOR DESTINE AU TRAITEMENT OU A LA PREVENTION DE SYMPTOMES, DE TROUBLES OU DE MALADIES OPHTALMIQUES, ET SON APPLICATION
The present invention provides a medicine and a method for preventing or treating ophthalmic symptoms, disorders, or diseases. The present invention provides an mTOR-inhibitor-containing composition for preventing or treating ophthalmic symptoms, disorders, or diseases. In some of the embodiments of the present invention, this composition is capable of treating or preventing corneal endothelial symptoms, disorders, or diseases； in particular, corneal endothelial symptoms, disorders, or diseases that are attributed to overexpression of the transforming growth factor-ß (TGF-ß) signal and/or extracellular matrix (ECM).
